Prapela
Pre-clinicalPrapela - a vibrating / stimulation therapy for newborns. Introducing a hospital bassinet pad to reduce the suffering of opioid exposed babies. The first and only device with FDA marketing authorization to treat neonatal opioid exposed newborns (NOWS), also known as Neonatal Abstinence Syndrome (NAS). Our incubator pad is in a clinical trial to help reduce apnea, improve breathing, and oxygenation in preterm newborns.
About
Prapela - a vibrating / stimulation therapy for newborns. Introducing a hospital bassinet pad to reduce the suffering of opioid exposed babies. The first and only device with FDA marketing authorization to treat neonatal opioid exposed newborns (NOWS), also known as Neonatal Abstinence Syndrome (NAS). Our incubator pad is in a clinical trial to help reduce apnea, improve breathing, and oxygenation in preterm newborns.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile